Gobal pharma major Lupin Limited has announced the launch of a novel fixed-dose triple drug combination (FDC) of Indacaterol, Glycopyrronium and Mometasone, under the brand name DIFIZMA in India, for managing inadequately controlled asthma among...
Aurobindo Pharma on said its wholly-owned subsidiary Eugia Pharma Specialities received final approval from the US Food and Drug Administration (US FDA) to manufacture and market Azacitidine for injection 100 mg single-dose vial....
Geron Corp's shares rose 50% after the company announced that its experimental blood cancer drug helped more patients achieve blood transfusion independence when compared to a placebo in a late-stage trial. Imetelstat, Geron's lead drug, was being...
Everest Medicines, a biopharmaceutical company, has announced its strategic plans for the next two years and beyond, as the company strives to become a fully-integrated biopharmaceutical company with expertise and capabilities spanning the entire...
Granules India Limited, enters into a strategic partnership with Greenko ZeroC to collaborate for green molecule solutions and its wider applications in pharmaceuticals to build a leadership position in sustainability and circular economy...
BDR Pharmaceutical has launched the first generic Apalutamide (Brand name Apatide) in India to treat metastatic castration-sensitive prostate cancer (mCSPC) and non-metastatic castration-resistant prostate cancer (nmCRPC). ..
Zydus Lifesciences Ltd said it has received final approval from the US health regulator to market its generic version of Triazolam tablets used on a short-term basis to treat insomnia. The approval granted by the US Food and Drug Administration...
The government said it has signed a pact with the Pune-based Institute of Veterinary Biological Products (IVBP) for commercial production of indigenously developed vaccine 'Lumpi-ProVac' for the control of lumpy skin disease in cattle...
Cipla said that its wholly owned UK subsidiary has signed definitive agreements for equity investment of EUR 15 million in Ethris, a global leader in delivering mRNAs directly to the respiratory system including administration by inhalation...
In this article we have combined four promising trends in SUT that is expected to have a lasting impact on the pharmaceutical industry.
, CDSCO.jpg)
